Randal Lepow, DPM
Podiatrist · Houston, TXNPI 1245210830
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (29.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 42 manufacturers reported payments, led by Kerecis Limited at 49.2% of the total. Reporting peaked in 2022 at $11,445 and has fallen 92.8% since, to $827 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 260 payments — averaging $125.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$16K
- Medinc Of Texas$5K
- Biotissue Holdings Inc.$3K
- Stryker$2K
- Smith+Nephew$2K
- Medline Industries LP$602
- plus $5K from 36 others
Across 1 payment — averaging $1600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Skye Orthobiologics LLC$2K
What the payments were for
- Consulting fees$3,75011%
- Speaking & faculty fees$5,81318%
- Travel & lodging$8,41826%
- Food & beverage$9,70230%
- Education$5,01315%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$32,309
- Kerecis Omega3 SurgiClose$29,341
- Kerecis Omega3 GraftGuide$15,489
- VARIAX$694
- Kerecis Omega3 Wound$608
- Versajet$566
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$397
- TOTAL FOOT SYSTEM$397
- CADENCE ANKLE REPLACEMENT SYSTEM$397
- MIRRAGEN ADVANCED WOUND MATRIX$344
- ALLOWRAP$288
- VHT-200 Wound Treatment System$260
- Dermatology and Wound Care$247
- ARISTA AH FLEXITIP$239
- COLLAGENASE SANTYL$237
- NUZYRA$229
- BIO4$144
- PRODIGY$139
- NEOX$136
- CLARIX$136
How this compares
$32,696 in reported general payments places this provider in the 90th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 59 | $32,266 |
| Ciclopirox | 42 | $1,441 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 34 | $964 |
| Ammonium Lactate | 29 | $860 |
| Cephalexin | 32 | $266 |
| Clindamycin Hcl | 23 | $251 |
| Methylprednisolone | 34 | $166 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $162 |
| Levofloxacin | 17 | $105 |
| Terbinafine Hcl | 13 | $93 |
| Tramadol Hcl | 17 | $62 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,846 | $32,26659 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 470 podiatrist providers in Texas.
Other podiatrist in Houston
- Gary LepowHouston$1M
- Andrew SchneiderHouston$150K
- Randall BeckmanHouston$103K
- Jason ArmstrongHouston$91K
- Jerry MilesHouston$58K
- Tina OliverHouston$42K
- Lawrence MactavishHouston$41K
- Roberto de Los SantosHouston$33K
- Ava WashkoHouston$19K
- Jeffrey RossHouston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.